DexCom, Inc. (NASDAQ:DXCM) is one of the best strong buy growth stocks to buy now. On August 21, Argus initiated coverage of DexCom, Inc. (NASDAQ:DXCM) with a Buy rating and $100 price target. Why ...

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...

Investing.com -- Dexcom (NASDAQ:DXCM), Inc. is recalling certain glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The recall ...

Medicare Part B typically covers continuous glucose monitors (CGMs) like the Dexcom G7, as they are Food and Drug Administration (FDA)-approved durable medical equipment items. To get a Dexcom G7 CGM ...

Monitoring your blood sugar levels is crucial for effective diabetes management. It helps you understand how different factors, such as diet and exercise, impact your blood sugar range. A healthy ...

Blood sugar levels play a crucial role in our overall health, and maintaining them within a healthy range is essential for preventing various diseases. The ideal blood sugar range varies depending on ...

An interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...

Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99. Stelo ...

The diabetes tech firm tailored its software to the 25 million people in the U.S. who have Type 2 diabetes and do not use insulin. The device is similar to existing prescription CGMs. Users pair the ...